nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing new vaccines against pandemic influenza in low-resource countries
|
Berlanda Scorza, Francesco |
|
2017 |
35 |
40 |
p. 5397-5402 |
artikel |
2 |
A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles
|
Watkins, Hannah C. |
|
2017 |
35 |
40 |
p. 5373-5380 |
artikel |
3 |
Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12
|
Donahue, James G. |
|
2017 |
35 |
40 |
p. 5314-5322 |
artikel |
4 |
Challenges and efforts in vaccine development and distribution
|
Käser, Tobias |
|
2017 |
35 |
40 |
p. 5396 |
artikel |
5 |
Commentary on: “Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12”
|
Chambers, Christina D. |
|
2017 |
35 |
40 |
p. 5323-5324 |
artikel |
6 |
Developing and financing neglected disease vaccines in our new era of “blue marble health” and the anthropocene epoch
|
Hotez, Peter J. |
|
2017 |
35 |
40 |
p. 5403-5405 |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
2017 |
35 |
40 |
p. IFC |
artikel |
8 |
Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid
|
Latasa, P. |
|
2017 |
35 |
40 |
p. 5381-5387 |
artikel |
9 |
Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle
|
Scott, Katherine A. |
|
2017 |
35 |
40 |
p. 5426-5433 |
artikel |
10 |
Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge
|
Brandt, Kevin S. |
|
2017 |
35 |
40 |
p. 5310-5313 |
artikel |
11 |
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2–17-year-old children with asplenia or splenic dysfunction: A phase 3 study
|
Szenborn, L. |
|
2017 |
35 |
40 |
p. 5331-5338 |
artikel |
12 |
Intention to accept pertussis vaccine among pregnant women in Karachi, Pakistan
|
Siddiqui, Mariam |
|
2017 |
35 |
40 |
p. 5352-5359 |
artikel |
13 |
Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines
|
Xiao, Yuhong |
|
2017 |
35 |
40 |
p. 5418-5425 |
artikel |
14 |
Methyl pentose (6-deoxy hexose) content in the polysaccharides of Streptococcus pneumoniae serotypes 4, 5 and 12F: Incorrect sugar composition specification in WHO TRS977
|
Rajendar, Burki |
|
2017 |
35 |
40 |
p. 5309 |
artikel |
15 |
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
|
Smith, Gale |
|
2017 |
35 |
40 |
p. 5366-5372 |
artikel |
16 |
Pneumococcal conjugate vaccine use in adults – Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia
|
Sings, Heather L. |
|
2017 |
35 |
40 |
p. 5406-5417 |
artikel |
17 |
Prevention of treatable infectious diseases: A game-theoretic approach
|
Jijón, Sofía |
|
2017 |
35 |
40 |
p. 5339-5345 |
artikel |
18 |
Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine
|
López-Fauqued, Marta |
|
2017 |
35 |
40 |
p. 5325-5330 |
artikel |
19 |
Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications
|
McLaughlin, John M. |
|
2017 |
35 |
40 |
p. 5360-5365 |
artikel |
20 |
The road to a more effective influenza vaccine: Up to date studies and future prospects
|
Sano, Kaori |
|
2017 |
35 |
40 |
p. 5388-5395 |
artikel |
21 |
Vaccine exemptions and the kindergarten vaccination coverage gap
|
Smith, Philip J. |
|
2017 |
35 |
40 |
p. 5346-5351 |
artikel |